InvestorsHub Logo
Followers 5
Posts 313
Boards Moderated 0
Alias Born 04/10/2013

Re: None

Wednesday, 09/18/2013 2:12:05 PM

Wednesday, September 18, 2013 2:12:05 PM

Post# of 403310
What I think is being overlooked is that we are holding strong with a 200MM valuation in the market. Certainly I understand frustration with the share price which seems like its being held down but lets consider this. We have one compound in a phase 1 trial. Breakthrough potential or not, the market is giving us a valuation that typically isn't realized until phase 3, for cancer drugs. The best part is we are months ( 2-3?) from having at least one phase 2b and one phase 2/3 trial for two additional compounds. We are also months (4-6?) from having MTD for K or at least confirmed p21 and possible signs of efficacy beyond the restagings ie., shrinkage?. We are months (6-8?) away from at least one additional K tria.l We are also months (2-4?) from an IND and additional phase 2 for Brilacidin. We are months away from up listing. What will the market place value us at then? If we go by the fact that the market has been giving us premium valuation ahead of major events it seems we can make the case that it will continue to do so. I think that we are in the sweet spot now!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News